phytocannabinoidCannabidiol (CBD) (CBD)
- Articles
- 34
- Study records
- 3
- Medicine records
- 0
- Indexed span
- 2015-2026
Loading condition report…
Loading condition report…
A class of traumatic stress disorders with symptoms that last more than one month.
Evidence at a glance
Open any number to go directly to the underlying records.
The report maps directly scoped documents, study registrations, formulations and exact source-reported evidence. Efficacy, treatment and safety conclusions remain unvalidated. Every item links back to preserved source material. Study registrations and dose records describe what researchers reported or planned; they are not treatment advice or proof that an intervention works.
Condition scope
Subtype counts can overlap because one article may discuss more than one condition.
Research map
These are document-level associations. The first group has study-registration or regulatory context; neither group proves efficacy or clinical use.
How treatment was studied
Routes and dose values below describe registered or published research. They are not prescribing instructions.
What researchers planned or recorded in trial registrations.
No exact dose descriptions were present in this frozen report snapshot.
How the intervention was described as being given in registered studies.
Open a route to see its registrations. A study may appear under more than one route.
Source-backed observations from readable publications.
Systematic review: researchers use a documented method to find, select and assess all relevant studies for a specific question.
Meta-analysis: when the studies are sufficiently comparable, their numerical results are combined statistically.
These methods can provide a broader view than one study, but their reliability still depends on the quality and similarity of the included evidence. They do not automatically prove that a treatment works.
No publication-level dosing evidence is available in this frozen snapshot.
How the research was designed
These labels describe the registered study design—not whether the treatment worked. A study can use several methods, so categories may overlap. Protocol categories are deterministic title/type matches and use a multi-label taxonomy. Filters preserve every matching tag while each registration is shown once. Registration is not a result.
Showing 8 of 8 unique registrations. 8 pattern memberships are preserved as badges; counts may overlap.
Research frequency
Counts use the directly scoped, rights-cleared article snapshot. The current year is partial.
Registries
A registration describes the protocol. When posted, source-reported outcomes and safety are preserved on the local Study page.
Browse the complete filtered study catalog →
Showing 12 of 17 directly scoped registrations.
180 enrolled
Open study record170 enrolled
Open study record80 enrolled
Open study record86 enrolled
Open study record11 enrolled
Open study record320 enrolled
Open study record21 enrolled
Open study record0 enrolled
Open study record36 enrolled
Open study recordEnrollment not reported
Open study record65 enrolled
Open study record0 enrolled
Open study recordSupporting evidence and regulatory context
Available items are locally preserved, frozen candidates. Funding and related research remain unavailable until a complete relevance-policy-v2 section is frozen; unavailable safety linkage is never presented as zero. Source metadata and safety reports are not efficacy or causality claims.
Frozen 14/09/2026 · 3,175 records · source sync still in progress
The objective of this application is to use ecological momentary assessment and contingency management to study the impact of reduced cannabis use on psychosocial functioning among Veterans with posttraumatic stress disorder (PTSD). Findings from this study will directly address the ongoing national debate regarding whether cannabis use promotes or hinders the functional recovery of Veterans with PTSD. Our central hypothesis is that reduced cannabis use will lead to improvements in Veterans’ functioning and quality of life.
Veterans and military personnel are at increased risk posttraumatic stress disorder (PTSD), and this disorder is associated with increased rates of alcohol use disorder (AUD). Individuals with PTSD+AUD have unique and greater PTSD symptoms and rates of alcohol use, and the comorbidity complicates treatment and delays outcomes. These data indicate that PTSD+AUD significantly impact the rehabilitative progress of PTSD patients. One mechanism implicated in the high rate of PTSD+AUD is impaired activity in the striatum, which is a brain region that governs reward and habit responding. This project aims to address the long-term effects of PTSD+AUD on striatal-based behaviors resulting from molecular, neurochemical and functional striatal impairments. A long-lasting rehabilitation strategy to use a cannabinoid receptor drug as a neurotherapeutic intervention that can be implemented upon return from active duty will be determined. Thus, these studies are highly relevant to VA patient care and rehabilitation.
PROJECT NARRATIVE This project aims to determine whether cannabidiol (CBD) is effective in treating alcohol use disorder (AUD) comorbid posttraumatic stress disorder (PTSD). To address this aim, we will conduct a clinical trial in which we administer CBD to fifty individuals with AUD comorbid with PTSD, and assess alcohol intake and PTSD symptoms.
PROJECT NARRATIVE This project aims to determine whether cannabidiol (CBD) is effective in treating alcohol use disorder (AUD) comorbid posttraumatic stress disorder (PTSD). To address this aim, we will conduct a clinical trial in which we administer CBD to fifty individuals with AUD comorbid with PTSD, and assess alcohol intake and PTSD symptoms.
The objective of this application is to use ecological momentary assessment and contingency management to study the impact of reduced cannabis use on psychosocial functioning among Veterans with posttraumatic stress disorder (PTSD). Findings from this study will directly address the ongoing national debate regarding whether cannabis use promotes or hinders the functional recovery of Veterans with PTSD. Our central hypothesis is that reduced cannabis use will lead to improvements in Veterans’ functioning and quality of life.
Veterans and military personnel are at increased risk posttraumatic stress disorder (PTSD), and this disorder is associated with increased rates of alcohol use disorder (AUD). Individuals with PTSD+AUD have unique and greater PTSD symptoms and rates of alcohol use, and the comorbidity complicates treatment and delays outcomes. These data indicate that PTSD+AUD significantly impact the rehabilitative progress of PTSD patients. One mechanism implicated in the high rate of PTSD+AUD is impaired activity in the striatum, which is a brain region that governs reward and habit responding. This project aims to address the long-term effects of PTSD+AUD on striatal-based behaviors resulting from molecular, neurochemical and functional striatal impairments. A long-lasting rehabilitation strategy to use a cannabinoid receptor drug as a neurotherapeutic intervention that can be implemented upon return from active duty will be determined. Thus, these studies are highly relevant to VA patient care and rehabilitation.
Veterans and military personnel are at increased risk posttraumatic stress disorder (PTSD), and this disorder is associated with increased rates of alcohol use disorder (AUD). Individuals with PTSD+AUD have unique and greater PTSD symptoms and rates of alcohol use, and the comorbidity complicates treatment and delays outcomes. These data indicate that PTSD+AUD significantly impact the rehabilitative progress of PTSD patients. One mechanism implicated in the high rate of PTSD+AUD is impaired activity in the striatum, which is a brain region that governs reward and habit responding. This project aims to address the long-term effects of PTSD+AUD on striatal-based behaviors resulting from molecular, neurochemical and functional striatal impairments. A long-lasting rehabilitation strategy to use a cannabinoid receptor drug as a neurotherapeutic intervention that can be implemented upon return from active duty will be determined. Thus, these studies are highly relevant to VA patient care and rehabilitation.
Veterans and military personnel are at increased risk posttraumatic stress disorder (PTSD), and this disorder is associated with increased rates of alcohol use disorder (AUD). Individuals with PTSD+AUD have unique and greater PTSD symptoms and rates of alcohol use, and the comorbidity complicates treatment and delays outcomes. These data indicate that PTSD+AUD significantly impact the rehabilitative progress of PTSD patients. One mechanism implicated in the high rate of PTSD+AUD is impaired activity in the striatum, which is a brain region that governs reward and habit responding. This project aims to address the long-term effects of PTSD+AUD on striatal-based behaviors resulting from molecular, neurochemical and functional striatal impairments. A long-lasting rehabilitation strategy to use a cannabinoid receptor drug as a neurotherapeutic intervention that can be implemented upon return from active duty will be determined. Thus, these studies are highly relevant to VA patient care and rehabilitation.
Unavailable. Governed relevance linkage is not ready for this frozen snapshot; no absence of records is inferred.
No matching records in this frozen snapshot.
FAERS package linkage is unavailable; zero reports must not be inferred until exact governed medicine links are ready.
Regulatory records
Registry Results
Registry-submitted primary-outcome values are shown with exact local provenance. The service does not infer efficacy, effect direction or a treatment recommendation from these unreviewed values.
The registry has not posted a Results section for these records. A protocol does not show whether the intervention worked.No registry Results section is pinned in this frozen report snapshot.
A registration describes what was planned. It does not show whether the intervention worked.
Safety
The linked evidence is source-reported and remains candidate-only. Contraindications and patient-specific guidance are not yet validated.
Latest additions
The articles, studies and medicine records shown here are fixed to one dated snapshot. Their source identifiers and links were checked, but the platform has not turned registry entries into clinical conclusions.
This condition is normalized as D013313 using Medical Subject Headings 2026.
8,147 source identifiers verified · snapshot record 6129cc37e2b1...Dates are derived from this report's immutable package pins. A failed refresh does not replace the last good report.
Limits
Showing 12 of 3,144 frozen records. Browse the complete set →